Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 14, 2020

Total Value ($000): $94,557 (96.9% shares, 3.1% debt)

Holdings (27)

LGND LIGAND PHARMACEUTICALS 12.4%
Value ($000) $11,702 Shares 160,919 Est. Cost $56.68 Unrealized 0.0%
IVERIC BIO INC 9.4%
Value ($000) $8,888 Shares 2,583,786 Est. Cost $1.30 Unrealized
CTI BIOPHARMA CORP 6.3%
Value ($000) $5,916 Shares 6,430,637 Est. Cost $2.16 Unrealized
AMARIN CORP PLC -ADR 5.6%
Value ($000) $5,252 Shares 1,313,100 Est. Cost $9.14 Unrealized
AFFIMED NV 5.0%
Value ($000) $4,740 Shares 3,000,000 Est. Cost $2.75 Unrealized
CATALYST BIOSCIENCES INC 4.7%
Value ($000) $4,454 Shares 1,019,196 Est. Cost $5.11 Unrealized
STEMLINE THERAPEUTICS INC 4.5%
Value ($000) $4,291 Shares 886,632 Est. Cost $4.84 Unrealized
XOMA XOMA CORP 4.5%
Value ($000) $4,245 Shares 208,600 Est. Cost $14.24 Unrealized +62.1%
OPIANT PHARMACEUTICALS INC 3.9%
Value ($000) $3,649 Shares 380,948 Est. Cost $15.15 Unrealized
NEOS THERAPEUTICS INC 3.7%
Value ($000) $3,518 Shares 4,690,146 Est. Cost $1.80 Unrealized
OXFORD IMMUNOTEC GLOBAL PLC 3.7%
Value ($000) $3,467 Shares 374,431 Est. Cost $16.13 Unrealized
EOLS EVOLUS INC 3.6%
Value ($000) $3,415 Shares 822,960 Est. Cost $11.17 Unrealized -24.2%
ADAMAS PHARMACEUTICALS INC 3.6%
Value ($000) $3,361 Shares 1,162,876 Est. Cost $4.81 Unrealized
CPIX CUMBERLAND PHARMACEUTICALS 3.5%
Value ($000) $3,295 Shares 907,735 Est. Cost $5.80 Unrealized -22.9%
APOLLO ENDOSURGERY INC 3.4%
Value ($000) $3,233 Shares 1,683,861 Est. Cost $4.35 Unrealized
CIDARA THERAPEUTICS INC 3.4%
Value ($000) $3,231 Shares 1,302,981 Est. Cost $2.48 Unrealized
AEGERION PHARMACEUTICALSAEGR 5 04/01/25 3.1%
Value ($000) $2,886 Shares 3,037,627 Est. Cost $0.95 Unrealized
BIODELIVERY SCIENCES INTL 3.0%
Value ($000) $2,861 Shares 755,000 Est. Cost $3.79 Unrealized
CHIASMA INC 2.9%
Value ($000) $2,716 Shares 744,134 Est. Cost $3.97 Unrealized
DMAC DIAMEDICA THERAPEUTICS INC 2.4%
Value ($000) $2,311 Shares 825,297 Est. Cost $4.13 Unrealized 0.0%
SEASPINE HOLDINGS CORP 2.2%
Value ($000) $2,068 Shares 253,131 Est. Cost $8.17 Unrealized
APPLIED GENETIC TECHNOLOGIES 2.0%
Value ($000) $1,925 Shares 586,969 Est. Cost $3.28 Unrealized
BAUDAX BIO INC 1.6%
Value ($000) $1,513 Shares 610,200 Est. Cost $2.48 Unrealized
IDXG INTERPACE BIOSCIENCES INC 1.0%
Value ($000) $924 Shares 178,295 Est. Cost $0.50 Unrealized
ANTARES PHARMA INC 0.4%
Value ($000) $357 Shares 151,189 Est. Cost $2.36 Unrealized
HTG MOLECULAR DIAGNOSTICS 0.3%
Value ($000) $323 Shares 992,641 Est. Cost $1.63 Unrealized
RIGEL PHARMACEUTICALS INC 0.0%
Value ($000) $16 Shares 10,000 Est. Cost $1.60 Unrealized